Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
Marketline
Zugriff auf die Ressource
Öffnen Sie den Inhalt über die Hauptoption oder wählen Sie eine andere verfügbare Quelle.
Institutioneller Zugriff verfügbar
Zitieren
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Marketline (s. f.). Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site
MLA
Marketline. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Chicago
Marketline. s. f. Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales. Marketline. https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site.
Harvard
Marketline s. f, Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales, Marketline, available at: https://search.ebscohost.com/direct.asp?db=bth&jid=8P21&scope=site [Accessed 10 Aug. 2026].
Ressourcendetails
Bibliografische Angaben zur Prüfung, ob es sich um das richtige Material handelt.
- Titel
- Neurological Disease Diagnostics Case Study (Huntington's & Alzheimer's Disease): Quantifying the Impact of Improved Biomarkers on Drug Sales
- Autor / Mitwirkende
- Marketline
- Verlag
- Marketline